bullish

Gushengtang

Gushengtang (2273.HK) - The Development Momentum Is Good, but There Are Also Challenges

294 Views28 Jun 2022 08:40
Gushengtang's business model works well, but increasing competition and weak healthcare product sales could negatively affect performance. 2022 revenue growth could decline but EPS could turn positive
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x